Download PDF
CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2022; 12(04): 392-397
DOI: 10.1055/s-0041-1741431
Original Article

Psychological Impact Assessment in Patients with Noncommunicable Diseases during COVID-19 Pandemic through Validated Fear of COVID-19 scale: A Cross-Sectional Online Survey

Hima B. Ponnam 
1   Drug Standardisation Unit (Homoeopathy), Central Council for Research in Homoeopathy, Ministry of Ayush, Govt. of India, Hyderabad, Telangana, India
,
Butchi R. Akondi
2   Department of Clinical Pharmacy and Pharmacology, Ibn sina National College for Medical Studies, Jeddah, Saudi Arabia
,
Santosh K. Jagadabhi
3   Department of Physiology, Jeeyar Integrative Medical Services Homoeopathic Medical College and Hospital, Hyderabad, Telangana, India
,
Divya T. Koppula 
1   Drug Standardisation Unit (Homoeopathy), Central Council for Research in Homoeopathy, Ministry of Ayush, Govt. of India, Hyderabad, Telangana, India
,
Shanmukha P. Konduru
1   Drug Standardisation Unit (Homoeopathy), Central Council for Research in Homoeopathy, Ministry of Ayush, Govt. of India, Hyderabad, Telangana, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Background The novel coronavirus disease 2019 (COVID-19) pandemic has created immense panic globally with its advent in December 2019 and now showing readvent with its camouflage of different dangerous mutant strains. Its psychological repercussions on the community are very disastrous and immeasurable. At this juncture, the most vulnerable group are the patients of Noncommunicable diseases (NCDs) who are the most sufferers due to the impact caused by the anxiety and fear of COVID-19 apart from its high rate of infectivity. In this context, an online survey to assess the levels of anxiety and fear of COVID-19 in patients with lifestyle diseases has been taken up.

Methods This was an online cross-sectional survey using the Fear of COVID-19 Scale (FCV-19S) to assess the levels of anxiety and fear in patients with NCDs. The survey was made available for both genders and an age group of 30 years and above in India.

Results and Discussion A total of 627 participants participated in this online survey. The Indian residents with NCDS )Noncommunicable diseases) were found to suffer from significantly increased levels of anxiety and fear of COVID-19 and almost 60.4% of the participants were found to acquire these lifestyle diseases as diabetes and hypertension during this recent COVID-19 times.

Conclusion This survey shows the real-time psychological impact of COVID-19 which has a disastrous effect upon the community especially on the patients with NCDs who are the most vulnerable group. The study findings corroborate with the recent studies conducted on NCDs.

Keywords

COVID-19 pandemic - cross-sectional survey - FCV-19S - fear of COVID-19 scale - India - noncommunicable diseases - NCD


Publication History

Article published online:
18 January 2022

© 2022. Nitte (Deemed to be University). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Lim MA, Huang I, Yonas E, Vania R, Pranata R. A wave of non-communicable diseases following the COVID-19 pandemic. Diabetes Metab Syndr 2020; 14 (05) 979-980
    CrossrefPubMedGoogle Scholar
  • 2 Rahman ARA. Latest evidence on non-communicable disease management (NCD) during COVID-19 pandemic. IJHHS 2021; 5: 10
    Google Scholar
  • 3 World Health Organization. The Impact of the COVID-19 Pandemic on Noncommunicable Disease Resources and Services: Results of a Rapid Assessment. Geneva, Switzerland: World Health Organization; 2020
    Google Scholar
  • 4 Nethan S, Sinha D, Mehrotra R. Non communicable disease risk factors and their trends in India. Asian Pac J Cancer Prev 2017; 18 (07) 2005-2010
    PubMedGoogle Scholar
  • 5 Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict 2020; (e-pub ahead of print) DOI: 10.1007/s11469-020-00270-8.
    CrossrefPubMedGoogle Scholar
  • 6 Andrade EF, Pereira LJ, Oliveira APL. et al. Perceived fear of COVID-19 infection according to sex, age and occupational risk using the Brazilian version of the Fear of COVID-19 Scale. Death Stud 2020; (e-pub ahead of print) DOI: 10.1080/07481187.2020.1809786.
    CrossrefPubMedGoogle Scholar
  • 7 Haktanir A, Seki T, Dilmaç B. Adaptation and evaluation of Turkish version of the fear of COVID-19 Scale. Death Stud 2020; (e-pub ahead of print) DOI: 10.1080/07481187.2020.1773026.
    CrossrefPubMedGoogle Scholar
  • 8 Huarcaya-Victoria J, Elera-Fitzcarrald C, Salvador-Carrillo J, Flores CJ. Psychometric properties of the Spanish version of the fear of COVID-19 scale in Peruvian medical students. Death Stud 2021; 0 (00) 1-7 10.
    Google Scholar
  • 9 Thakur JS, Paika R, Singh S, Narain JP. COVID-19 and noncommunicable diseases: Impact and the strategic approaches. Int J Noncommun Dis 2020; 5: 29-35 DOI: 10.4103/jncd.jncd_35_20.
    CrossrefGoogle Scholar
  • 10 BOARD OF GOVERNORS, In supersession of the Medical Council of India. Telemedicine practice guidelines: enabling registered medical practitioners to provide healthcare using telemedicine. Accessed April 16, 2021 at: https://www.mohfw.gov.in/pdf/Telemedicine.pdf
    Google Scholar
  • 11 Merzel C, D'Afflitti J. Reconsidering community-based health promotion: promise, performance, and potential. Am J Public Health 2003; 93 (04) 557-574
    CrossrefPubMedGoogle Scholar